← Home / CERENOME, INC. (PSTV)
Stock Analysis

CERENOME, INC. (PSTV)

PSTV
PSTV · Healthcare • Biotechnology
3.84 -0.57%
Track PSTV in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when PSTV price is:
52W Range Position
5%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-26 21:16 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and structural levels before acting.
⚖️
✓
Fundamentals
Weak / Negative / Pressured / Strong
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
3.64
↗
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
14
●
Financial Results
HIGH
PSTV reports financial results
(the “Company”) reported financial results for the first quarter ended March 31, 2026 and other recent corporate updates.
8-K Filing • SEC EDGAR
JUN
5
↗
Equity Offering / Capital Raise
HIGH
PSTV equity financing update
On June 1, 2026, Plus Therapeutics, Inc.
8-K Filing • SEC EDGAR
MAY
15
●
Financial Results
HIGH
Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
HOUSTON, May 15, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc.
8-K Filing • SEC EDGAR
What's Driving PSTV?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Revenue growth is weak. Profitability is negative. Cash generation is pressured. Balance-sheet quality is strong.
⚠️ Key risk remains
losing 3.64 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
45.8
Price Chart
PSTV — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-25
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$26.6M
Company size
EV
$12.2M
Debt-adjusted value
P/E
0.2
Low multiple
P/S
5.1
Balanced
P/B
2.2
Balanced
EV/Sales
2.4
Low sales multiple
EV/EBIT
-0.3
Not meaningful
P/FCF
-1.8
Not meaningful
Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
411,000
↘ Weak
📈 Net Income
-9.01M
↘ Negative
🧮 EPS (Basic)
-1.31
↘ Negative
CERENOME, INC.
Healthcare • Biotechnology
You Might Also Like